Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Medtronic
Merck
Dow
Mallinckrodt

Last Updated: December 9, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Thymopentin

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Thymopentin?

Thymopentin is an investigational drug.

There have been 8 clinical trials for Thymopentin. The most recent clinical trial was a Phase 3 trial.

The most common disease conditions in clinical trials are HIV Infections, Infection, and Communicable Diseases. The leading clinical trial sponsors are Immunobiology Research Institute, Fudan University, and [disabled in preview].

Recent Clinical Trials for Thymopentin
TitleSponsorPhase
Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular CarcinomaFudan UniversityPhase 3
Double Blind Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected PatientsImmunobiology Research InstituteN/A
A Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected PatientsImmunobiology Research InstituteN/A

See all Thymopentin clinical trials

Clinical Trial Summary for Thymopentin

Top disease conditions for Thymopentin
Top clinical trial sponsors for Thymopentin

See all Thymopentin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Boehringer Ingelheim
Moodys
Baxter
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.